DIM
BSX icon

DC Investments Management’s Boston Scientific BSX Stock Holding History

DC Investments Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,736
Closed -$272K – 104
2020
Q2 		$272K Buy
+7,736
New +$279K 0.1% 252
2018
Q3 		– Sell
-6,911
Closed -$226K – 280
2018
Q2 		$226K Buy
+6,911
New +$208K 0.14% 283
2018
Q1 		– Sell
-23,237
Closed -$576K – 257
2017
Q4 		$576K Buy
+23,237
New +$641K 0.24% 113

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DC Investments Management's BSX Position: Q3 2020 in Review

DC Investments Management sold out of Boston Scientific (BSX) in Q3 2020, closing a stake of 7,736 shares — an estimated $272K sold.

DC Investments Management first reported a position in BSX in Q4 2017 and held it in 3 quarters. The position peaked at $576K in Q4 2017. 843 funds tracked by Wall St. Rank hold BSX as of Q3 2020.

  • DC Investments Management reported no remaining Boston Scientific position as of Q3 2020 after selling out during the quarter.
  • DC Investments Management sold 7,736 Boston Scientific shares in Q3 2020, an estimated $272K.
  • DC Investments Management first reported a position in Boston Scientific in Q4 2017 and held it in 3 quarters.
  • DC Investments Management's Boston Scientific position peaked at $576K in Q4 2017.
  • 843 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.